Randomized trial evaluates bentonite's effect on growth in juvenile Nile tilapia, suggesting benefits against aflatoxin exposure.
Previous studies evaluating bentonite in Nile tilapia have largely employed high-dose AFB1 challenge models (≥2 ppm in the diet), whereas information on its efficacy under sub-acute contamination conditions is limited. This study evaluated the effects of a bentonite-based binder on growth performance and selected gross health-related indices in juvenile Nile tilapia exposed to 250 ppb dietary AFB1. In a 42-day feeding trial, 320 fish were randomly assigned to four treatments: a negative control (NC; no AFB1 or binder), a positive control (PC; 250 ppb AFB1), and two AFB1-contaminated diets supplemented with bentonite at 1 kg/ton (TMX-1) or 2 kg/ton (TMX-2). Dietary AFB1 exposure to 250 ppb impaired growth and feed intake and increased body-weight variability compared with the NC group (p < 0.01). Bentonite supplementation elicited inclusion-level-dependent responses. Fish fed TMX-2 had higher final body weight (+7.0%) and average daily gain (+7.9%) than those fed the PC diet (p < 0.01), whereas TMX-1 performed similarly to the PC group. Feed conversion ratio differed among treatments, with TMX-2 lower than TMX-1 (p = 0.02) but not significantly different from the NC or PC groups. Mortality, condition factor, body-weight variation and organosomatic indices did not differ among AFB1-challenged treatments. These findings indicate that dietary bentonite supplementation, particularly at 2 kg/ton, partially alleviated adverse responses associated with sub-acute AFB1 exposure, primarily through improvements in final body weight and average daily gain, in juvenile Nile tilapia under the conditions of the present study.
No takes yet. Share an insight, caveat, or question.
Pineda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: